2021 Autumn Conference Posters

Click title to view pdf. Posters are listed in alpha order by first author.

Use of a pharmacogenomic biomarker to retarget a failed clinical trial with DB104 (Liafensine) in depression (Abstract)

Alphs

Subjective cognitive decline and cognitive task performance: patient selection via social media and digital assessment validity (Abstract)

Bilderbeck

Should placebo responders be excluded from RCTs? (Abstract)

Branders

Efficient assessment of emotional bias using item response theory and decision tree computerised adaptive testing (Abstract)

Cormack

M – Measuring within-child change in treatment studies of low-functioning children (Abstract)

Daniel

D – Assessing the severity of anxiety symptoms at study entry into acute schizophrenia clinical trials (Abstract)

Daniel

Investigating the proper adaptation of sleep scoring algorithms for pediatric trials (Abstract)

Dorffner

Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways to precise drug development (Abstract)

Fernandes

Qualitative analysis of the content validity of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) in schizophrenia An FDA-funded study (Abstract)

Horan

Multimodal AI based facial and acoustic biomarkers of negative symptoms in schizophrenia (Abstract)

Khan

Exploring discordant data in dementia clinical trials (Abstract)

Kott

Positive and negative symptom predominance in the screening period in acute schizophrenia trials: An exploratory analysis (Abstract)

Kott

Borderline across borderlines: Regional variation in who enters clinical trials (Abstract)

Micaletto

Impact of protocol design on between scale discrepancies in early AD clinical trials (Abstract)

Miller

Placebo Response Propensity Scale PRPS scores and probability of placebo response by disease severity (Abstract)

Morlock

Application of a novel analytic methodology to improve PANSS data quality and signal detection in a global clinical trial of schizophrenia (Abstract)

Opler

Scoring consistency checks for the Clinician Administered PTSD Scale CAPS (Abstract)

Rabinowitz

PORTICO – A case study in overcoming methodological challenges in borderline personality disorder clinical development (Abstract)

Ropacki

Monitoring of scale administration and videography improves quality in a study of a rare genetic neuromuscular disease (Abstract)

Roy

Methodological approaches to outliers in cognitive assessment for schizophrenia: A post-hoc analysis of the EMERGENT-1 study (Abstract)

Sauder

Thalamic structure and function in youth with and at familial risk for bipolar disorder (Abstract)

Singh

Is elevating BHB by a ketone ester supplement sufficient in reducing alcohol craving and consumption in alcohol use disorder? (Abstract)

Wiers